GLGC Gene Logic Inc. (MM)

Gene Logic Inc. (NASDAQ:GLGC) announced today that Chief Executive Officer and President Mark D. Gessler will present at the Thomas Weisel Partners 2005 Healthcare Conference held at the Four Seasons Hotel, Boston, Mass. The presentation will begin at 2:05 p.m. Eastern time on Friday, September 9, 2005. A live audio webcast of the presentation will be available through a link that will be posted on the Investors/Corporate Presentations section of the Gene Logic website, www.genelogic.com. The webcast will be archived for 30 days following the presentation. Gene Logic Overview Gene Logic is leading the transformation of pharmaceutical research and development with its extensive gene expression databases, pioneering efforts in toxicogenomics, sophisticated bioinformatics expertise, specialty nonclinical testing capabilities and cutting edge technology program for drug repositioning. Gene Logic technologies and services are used by many of the world's top pharmaceutical and biotechnology companies. Over 150 organizations and government agencies have benefited from Gene Logic's diverse portfolio of drug development services, enabling them to make more informed, more reliable and more predictive decisions at each point in the highly complex and costly drug development process. Founded in 1994, Gene Logic is headquartered in Gaithersburg, Md., with additional research and development facilities in Cambridge, Mass. and Berkeley, Calif. The Company maintains customer support operations in Europe and Asia and currently has about 450 employees worldwide. For more information, visit www.genelogic.com or call toll-free - 1/800/GENELOGIC.